Pharmaceutical preparations for the treatment of cancer and metabolic disorders, namely hyperinsulinemia, hyperglycemia, hyperleptinemia, hypoadiponectinemia, type 2 diabetes, obesity, metabolic syndrome, pre-diabetes and rheumatoid arthritis.
REGISTERED
on 20 Feb 2020
SYNDEVRX
SYNDEVRX INC.
1857954 · 18 Sep 2017
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for the treatment of cancer and metabolic disorders, namely hyperinsulinemia, hyperglycemia, hyperleptinemia, hypoadiponectinemia, type 2 diabetes, obesity, metabolic syndrome, pre-diabetes and rheumatoid arthritis.
Pharmaceutical preparations for the treatment of cancer and metabolic ...
